AT1 4.55% 2.3¢ atomo diagnostics limited

That is great news and another blue sky opportunity for Atomo in...

  1. 1,448 Posts.
    lightbulb Created with Sketch. 866
    That is great news and another blue sky opportunity for Atomo in the future.

    I spoke with John Kelly at the Microcaps conference last month and he mentioned they will be commissioned by Nexsen to develop the technology.

    They must like what they see so far to also commit to manufacturing for pivotal clinical trials.

    Nexsen have received $5.5M in grant funding so far.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.